CereVasc, Inc.
Biotechnology company · Auburndale, Massachusetts, United States
CereVasc, Inc. is a biotechnology company headquartered in Auburndale, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2020.
CereVasc at a glance
What does CereVasc do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $11.1 million sold (2020).
Frequently asked questions about CereVasc
Where is CereVasc headquartered?
CereVasc, Inc. is headquartered in Auburndale, Massachusetts, United States.
What does CereVasc do?
CereVasc, Inc. is a biotechnology company.
When was CereVasc founded?
The earliest incorporation on record for CereVasc, Inc. is in 2020, according to public company registers.
Similar companies
- Advantagene, Inc.Auburndale, Massachusetts, United States
- Immunochem Therapeutics LLCAuburndale, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences